Press "Enter" to skip to content

New patent expiration for Valeant Pharms drug CARAC

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Valeant Pharms drug CARAC

Annual Drug Patent Expirations for CARAC
Annual Drug Patent Expirations for CARAC

Carac is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

CARAC drug price trends.

Drug patent litigation for CARAC.

The generic ingredient in CARAC is fluorouracil. Three suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Valeant Pharms drug CARAC
    Online Certificate Course

    Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

    • When will key drug patents expire?
    • How can I find, evaluate, and plan for generic market entry opportunities?
    • How can I find proprietary out-of-court settlements and deal terms?
    DrugPatentWatch - Make Better Decisions